Correspondence 0001493152-24-046307 from AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Inc.
Date: Nov. 15, 2024 · CIK: 0000946644 · Accession: 0001493152-24-046307
AI Filing Summary & Sentiment
Reasoning
Letter
SILVERMAN SHIN & SCHNEIDER PLLC
Wall Street Plaza
22nd Floor
Pine Street
NEW YORK, NY 10005
212.779.8600
Facsimile: 212.779.8858
E-mail: Rfeiner@Silverfirm.com
________
New Jersey
Engle Street
Tenafly, NJ 07670
(201) 567-4969
November 15, 2024
VIA EDGAR
Securities and Exchange Commission
F Street, NE
Washington, DC 20549
Re: AIM ImmunoTech Inc.
S-1 Registration Statement
Ladies and Gentlemen:
On behalf of AIM ImmunoTech Inc. (“AIM”) , a Delaware corporation, we hereby advise you that AIM submitted in electronic format for filing with the U. S. Securities and Exchange Commission (the “Commission”) , pursuant to the Securities Act of 1933, as amended, a registration statement on Form S-1.
Should any member of the Commission’s staff have any questions concerning the registration statement, please do not hesitate to contact me by phone (646) 822-1170, e-mail rfeiner@silverfirm.com or fax (917) 720-0863. The contact person at AIM is Peter W Rodino III, Chief Operating Officer, General Counsel & Secretary, phone (239) 444-1743, e-mail Peter.rodino@aimimmuno.com or fax (215) 988-1739.
Very truly yours,
s/ Richard Feiner
Show Raw Text
CORRESP
1
filename1.htm
SILVERMAN
SHIN & SCHNEIDER PLLC
Wall
Street Plaza
22nd
Floor
88
Pine Street
NEW
YORK, NY 10005
212.779.8600
Facsimile:
212.779.8858
E-mail:
Rfeiner@Silverfirm.com
________
New
Jersey
19
Engle Street
Tenafly,
NJ 07670
(201)
567-4969
November 15, 2024
VIA
EDGAR
Securities
and Exchange Commission
100
F Street, NE
Washington,
DC 20549
Re:
AIM ImmunoTech Inc.
S-1 Registration Statement
Ladies
and Gentlemen:
On
behalf of AIM ImmunoTech Inc. (“AIM”) , a Delaware corporation, we hereby advise you that AIM submitted in electronic format
for filing with the U. S. Securities and Exchange Commission (the “Commission”) , pursuant to the Securities Act of 1933,
as amended, a registration statement on Form S-1.
Should
any member of the Commission’s staff have any questions concerning the registration statement, please do not hesitate to contact
me by phone (646) 822-1170, e-mail rfeiner@silverfirm.com or fax (917) 720-0863. The contact person at AIM is Peter W Rodino III,
Chief Operating Officer, General Counsel & Secretary, phone (239) 444-1743, e-mail Peter.rodino@aimimmuno.com or fax (215)
988-1739.
Very truly yours,
s/ Richard Feiner
Richard Feiner
cc:
Peter Rodino